About the role

Aplyr's Quick Take

This role is for a Scientist or Senior Scientist focused on cardiac biology within a team developing technologies for organ preservation through cryopreservation. Day-to-day, you'll design and run experiments to test cryoprotectant solutions and assess their effects on cardiac cells using advanced models.

Good fit

Ideal candidates will have a strong background in cardiac biology or toxicology, with experience in experimental design and analysis. A collaborative mindset and a passion for innovative research in a high-stakes environment will help you thrive here.

Worth noting

The company is working on groundbreaking technology that could change organ transplantation, which may appeal to those motivated by impactful work. However, the role's specifics around daily tasks and team dynamics are somewhat vague.

Until is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, then rewarming them uniformly for transplant. By solving this grand challenge, we’re laying the foundation for whole-body reversible cryopreservation, giving patients a bridge to future cures.

To achieve our goal, we are assembling an interdisciplinary team to develop perfusion systems, cryoprotectant formulations, and vitrification and rewarming hardware.

We envision a future where no transplantable organ is lost to logistics, and no terminal diagnosis is final because patients can safely wait for future medicine to arrive.

About the Role

We are seeking a Scientist/Senior Scientist, Translational Cardiac Biology to join our team. You will be part of a multidisciplinary team that designs, builds, and characterizes new technologies that form the foundation of organ-scale reversible cryopreservation.

In this role, you will advance cryopreservation formulations by designing, executing, and analyzing high throughput experiments focused on cardiac biology and toxicology. You will establish novel approaches to characterize toxicity and permeability of new cryoprotectant solutions using cardiac cells (hiPSC-CMs, immortalized cells) and advanced 3D in vitro cardiac models. Your work will pioneer the use of predictive 2D and 3D models for toxicity assessment, helping enable human-sized organ preservation and bridging patients to future cures.

Skills & Tags

go ai design

Aplyr's read

UntilLabs is at the forefront of organ perfusion and translational cardiac biology, attracting scientists and engineers passionate about cutting-edge biomedical innovation.
Synthesized from recent postings & public sources

What's promising

•UntilLabs is pioneering advancements in organ perfusion technology.
•The company offers diverse roles from mechanical engineering to molecular development.
•Strong focus on interdisciplinary collaboration in biomedical research.

What to watch